Record overview
Status and phase
Status: TERMINATED
Phase: PHASE1, PHASE2
Sponsor: Wake Forest University Health Sciences
Condition: Head and Neck Cancer
NCT00573989
Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
Drug Supply Issue